Some people discover they can maintain on less than the maximum therapeutic dose
Mechanick JI, Harrell R, Allende-Vigo MZ, Alvayero C, Arita-Melzer O, Aschner P, et al
Compared against single-agent incretins Used in research as a benchmark against semaglutide, tirzepatide and retatrutide in the investigational obesity-pharmacology landscape
Toxicol Appl Pharmacol 154:287291 Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, Aposhian HV (2001) Human monomethylarsonic acid (MMA V ) reductase is a member of the glutathione- S -transferase superfamily
For patients with severe symptoms, treatment starts with 1000 mcg injected intramuscularly once daily for 7 days, then the frequency can vary to 1-3 times weekly for 4-8 weeks